Literature DB >> 12093914

Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects.

Christopher P Regan1, Wei Li, Diane M Boucher, Stephen Spatz, Michael S Su, Keisuke Kuida.   

Abstract

Erk5 is a mitogen-activated protein kinase, the biological role of which is largely undefined. Therefore, we deleted the erk5 gene in mice to assess its function in vivo. Inactivation of the erk5 gene resulted in defective blood-vessel and cardiac development leading to embryonic lethality around embryonic days 9.5-10.5. Cardiac development was retarded largely, and the heart failed to undergo normal looping. Endothelial cells that line the developing myocardium of erk5-/- embryos displayed a disorganized, rounded morphology. Vasculogenesis occurred, but extraembryonic and embryonic blood vessels were disorganized and failed to mature. Furthermore, the investment of embryonic blood vessels with smooth muscle cells was attenuated. Together, these data define an essential role for Erk5 in cardiovascular development. Moreover, the inability of Erk5-deficient mice to form a complex vasculature suggests that Erk5 may play an important role in controlling angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093914      PMCID: PMC123126          DOI: 10.1073/pnas.142293999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Mechanisms of angiogenesis and arteriogenesis.

Authors:  P Carmeliet
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

Review 2.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

3.  Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury.

Authors:  C P Regan; P J Adam; C S Madsen; G K Owens
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

4.  Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development.

Authors:  R H Adams; A Porras; G Alonso; M Jones; K Vintersten; S Panelli; A Valladares; L Perez; R Klein; A R Nebreda
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

5.  MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway.

Authors:  T H Chao; M Hayashi; R I Tapping; Y Kato; J D Lee
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

6.  Mekk3 is essential for early embryonic cardiovascular development.

Authors:  J Yang; M Boerm; M McCarty; C Bucana; I J Fidler; Y Zhuang; B Su
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

7.  Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis.

Authors:  J S Mudgett; J Ding; L Guh-Siesel; N A Chartrain; L Yang; S Gopal; M M Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

8.  ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain.

Authors:  H G Kasler; J Victoria; O Duramad; A Winoto
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 9.  A genetic blueprint for cardiac development.

Authors:  D Srivastava; E N Olson
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

10.  Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis.

Authors:  K Tamura; T Sudo; U Senftleben; A M Dadak; R Johnson; M Karin
Journal:  Cell       Date:  2000-07-21       Impact factor: 41.582

View more
  90 in total

1.  Tie1 deficiency induces endothelial-mesenchymal transition.

Authors:  Julie Garcia; Maria José Sandi; Pierre Cordelier; Bernard Binétruy; Jacques Pouysségur; Juan Lucio Iovanna; Roselyne Tournaire
Journal:  EMBO Rep       Date:  2012-05-01       Impact factor: 8.807

2.  Systematic discovery of nonobvious human disease models through orthologous phenotypes.

Authors:  Kriston L McGary; Tae Joo Park; John O Woods; Hye Ji Cha; John B Wallingford; Edward M Marcotte
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

Review 3.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

4.  Postselection thymocyte maturation and emigration are independent of IL-7 and ERK5.

Authors:  Michael A Weinreich; Stephen C Jameson; Kristin A Hogquist
Journal:  J Immunol       Date:  2010-12-27       Impact factor: 5.422

5.  Vitamin C promotes human endothelial cell growth via the ERK-signaling pathway.

Authors:  Gudrun Ulrich-Merzenich; Heike Zeitler; Darius Panek; Dirk Bokemeyer; Hans Vetter
Journal:  Eur J Nutr       Date:  2007-03       Impact factor: 5.614

Review 6.  Mitogen-activated protein kinases in heart development and diseases.

Authors:  Yibin Wang
Journal:  Circulation       Date:  2007-09-18       Impact factor: 29.690

7.  Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis.

Authors:  Sue J Sohn; Gavin M Lewis; Astar Winoto
Journal:  EMBO J       Date:  2008-06-12       Impact factor: 11.598

8.  Undermining the endothelium by ablation of MAPK-MEF2 signaling.

Authors:  Eric N Olson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

9.  Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure.

Authors:  Masaaki Hayashi; Sung-Woo Kim; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; E Dale Abel; Brian Eliceiri; Young Yang; Richard J Ulevitch; Jiing-Dwan Lee
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

10.  Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex.

Authors:  Tatiana Erazo; Ana Moreno; Gerard Ruiz-Babot; Arantza Rodríguez-Asiain; Nicholas A Morrice; Josep Espadamala; Jose R Bayascas; Nestor Gómez; Jose M Lizcano
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.